Decrease in Brain Distribution of Fluvoxamine in Experimental Hyperlipidemic Rats

Authors

  • Keizo Fukushima Kobe Gakuin University
  • Shinji Kobuchi
  • Masakazu Shibata
  • Kanji Takada
  • Nobuyuki Sugioka

DOI:

https://doi.org/10.18433/J3VG6T

Abstract

ABSTRACT: Purpose. Many clinical reports and trials have suggested that fluvoxamine (FLV) reduces plasma lipoprotein levels. However, few studies have reported the effect of plasma lipoproteins on FLV pharmacokinetics. The aim of the present study was to investigate the affinities of FLV to plasma lipoproteins and the effect of plasma lipoproteins on the biodistribution of FLV using an experimental hyperlipidemic (HL) rat model. Methods. HL rats were prepared by intraperitoneal administration of Poloxamer-407 solution (1.0 g/kg). In vitro protein binding and distribution of FLV in plasma lipoproteins were determined in control and HL rats. In vivo pharmacokinetic study (intravenous administration of FLV, 5.0 mg/kg) and biodistribution analysis for brain and liver at a steady state (infusion, 1.5 mg/kg/hr, 6 hrs) were also performed. Results. The plasma protein binding of FLV was around 83% and 95% in control and HL rats, respectively, whereas the FLV recoveries in triglyceride-rich lipoprotein fractions were increased in HL. Therefore, the elevation of lipoproteins was likely responsible for the increase in protein binding in HL. After intravenous administration, the area under the plasma concentration vs. time curve (AUC) in HL was 3.9-fold greater than that in control rats, whereas the distribution ratio of FLV plasma concentration to the brain at a steady state was decreased to approximately 20% of that of the control. Conclusions. FLV has an affinity to plasma lipoproteins, and their elevation might decrease the FLV biodistribution to brain; the plasma lipoprotein levels could not be found to correlate positively with the FLV pharmacokinetic effect in brain, but rather may attenuate it. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.

Downloads

Download data is not yet available.

Author Biography

Keizo Fukushima, Kobe Gakuin University

Assistant Professor Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences

Downloads

Published

2011-11-02

How to Cite

Fukushima, K., Kobuchi, S., Shibata, M., Takada, K., & Sugioka, N. (2011). Decrease in Brain Distribution of Fluvoxamine in Experimental Hyperlipidemic Rats. Journal of Pharmacy & Pharmaceutical Sciences, 14(3), 414–424. https://doi.org/10.18433/J3VG6T

Issue

Section

Pharmaceutical Sciences; Review Articles